132 related articles for article (PubMed ID: 32865163)
41. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population.
Cáliz R; del Amo J; Balsa A; Blanco F; Silva L; Sanmarti R; Martínez FG; Collado MD; Ramirez Mdel C; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Andreu JL; Graell E; Simon L; Martínez A; Mulero J
Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028
[TBL] [Abstract][Full Text] [Related]
42. Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis.
Liu B; Liu G; Liu B; Guo Y; Peng N; Li T
World J Surg Oncol; 2024 Jan; 22(1):19. PubMed ID: 38212758
[TBL] [Abstract][Full Text] [Related]
43. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity.
Haase R; Elsner K; Merkel N; Stiefel M; Mauz-Körholz C; Kramm CM; Körholz D
Klin Padiatr; 2012 Apr; 224(3):156-9. PubMed ID: 22513795
[TBL] [Abstract][Full Text] [Related]
44. [Association between mthfr gene polymorphisms and toxicity of HDMTX chemotherapy in acute lymphocytic leukemia].
Liu JX; Chen JP; Tan W; Lin DX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):488-92. PubMed ID: 18549614
[TBL] [Abstract][Full Text] [Related]
45. Associations between the C677T and A1298C polymorphisms of MTHFR and the efficacy and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
Lee YH; Song GG
Clin Drug Investig; 2010; 30(2):101-8. PubMed ID: 20067328
[TBL] [Abstract][Full Text] [Related]
46. Association of MTHFR C677T, MTHFR A1298C, and MTRR A66G Polymorphisms with Neural Tube Defects in Tunisian Parents.
Nasri K; Midani F; Kallel A; Ben Jemaa N; Aloui M; Boulares M; Lassoued M; Ben Halima M; Ben Wafi S; Soussi M; Mahjoubi I; Baara A; Ben Fradj MK; Omar S; Feki M; Jemaa R; Gaigi SS; Marrakchi R
Pathobiology; 2019; 86(4):190-200. PubMed ID: 31238314
[TBL] [Abstract][Full Text] [Related]
47. Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia.
Wang SM; Sun LL; Zeng WX; Wu WS; Zhang GL
Cancer Chemother Pharmacol; 2014 Aug; 74(2):283-9. PubMed ID: 24908438
[TBL] [Abstract][Full Text] [Related]
48. Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.
Erčulj N; Kotnik BF; Debeljak M; Jazbec J; Dolžan V
Leuk Lymphoma; 2012 Jun; 53(6):1096-104. PubMed ID: 22074251
[TBL] [Abstract][Full Text] [Related]
49. The influence of MTHFR genetic polymorphisms on adverse reactions after methotrexate in patients with hematological malignancies: a meta-analysis.
Yao P; He X; Zhang R; Tong R; Xiao H
Hematology; 2019 Dec; 24(1):10-19. PubMed ID: 30024839
[TBL] [Abstract][Full Text] [Related]
50. Association of
Wang S; Zuo S; Liu Z; Ji X; Yao Z; Wang X
J Int Med Res; 2020 Feb; 48(2):300060519879588. PubMed ID: 31617429
[TBL] [Abstract][Full Text] [Related]
51. Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies.
Suthandiram S; Gan GG; Zain SM; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
Pharmacogenomics; 2014 Aug; 15(11):1479-94. PubMed ID: 25303299
[TBL] [Abstract][Full Text] [Related]
52. [Polymorphism of methylenetetrahydrofolate reductase and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy].
Gao CM; Lu JW; Toshiro T; Wu JZ; Cao HX; Chen HQ; Feng JF; Kazuo T
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1054-8. PubMed ID: 15769364
[TBL] [Abstract][Full Text] [Related]
53. Methylenetetrahydrofolate reductase polymorphisms, C677T and A1298C, are associated with methotrexate-related toxicities in Korean patients with rheumatoid arthritis.
Choe JY; Lee H; Jung HY; Park SH; Bae SC; Kim SK
Rheumatol Int; 2012 Jun; 32(6):1837-42. PubMed ID: 21773884
[TBL] [Abstract][Full Text] [Related]
54. The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia.
Shen Y; Wang Z; Zhou F; Jin R
Open Life Sci; 2021; 16(1):1203-1212. PubMed ID: 34761111
[TBL] [Abstract][Full Text] [Related]
55. [Effect of GSTP1 and MTHFR Gene Polymorphism on Side Effects of HD-MTX in ALL Children].
Li F; Yin DD; Zhou XL; Ma JM; Guo HM; Meng L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):723-728. PubMed ID: 28641625
[TBL] [Abstract][Full Text] [Related]
56. Association between methylenetetrahydrofolate reductase polymorphisms and the relapse of acute lymphoblastic leukemia: a meta-analysis.
He HR; Chen SY; You HS; Hu SS; Sun JY; Dong YL; Lu J
Pharmacogenomics J; 2014 Oct; 14(5):432-8. PubMed ID: 24637499
[TBL] [Abstract][Full Text] [Related]
57. Methylenetetrahydrofolate reductase gene polymorphisms in Egyptian Turner Syndrome patients.
Ismail MF; Zarouk WA; Ruby MO; Mahmoud WM; Gad RS
Acta Biochim Pol; 2015; 62(3):529-32. PubMed ID: 26217949
[TBL] [Abstract][Full Text] [Related]
58. MTHFR gene C677T and A1298C variants are associated with FMF risk in a Turkish cohort.
Nursal AF; Kaya S; Sezer O; Karakus N; Yigit S
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28543752
[TBL] [Abstract][Full Text] [Related]
59. Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival.
Gemmati D; Ongaro A; Tognazzo S; Catozzi L; Federici F; Mauro E; Della Porta M; Campioni D; Bardi A; Gilli G; Pellati A; Caruso A; Scapoli GL; De Mattei M
Haematologica; 2007 Apr; 92(4):478-85. PubMed ID: 17488658
[TBL] [Abstract][Full Text] [Related]
60. Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.
Ongaro A; De Mattei M; Della Porta MG; Rigolin G; Ambrosio C; Di Raimondo F; Pellati A; Masieri FF; Caruso A; Catozzi L; Gemmati D
Haematologica; 2009 Oct; 94(10):1391-8. PubMed ID: 19648163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
